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Wnt signaling is required for development of meso-
derm-derived lineages and expression of transcrip-
tion factors associated with the primitive streak. In
a functional screen, we examined the mesoderm-
inducing capacity of transcription factors whose ex-
pressionwasWnt-dependent in differentiating ESCs.
In contrast to many inactive factors, we found that
mesoderm posterior 1 (Mesp1) promoted mesoderm
development independently of Wnt signaling. Tran-
sient Mesp1 expression in ESCs promotes changes
associated with epithelial-mesenchymal transition
(EMT) and induction of Snai1, consistent with a role
in gastrulation. Mesp1 expression also restricted
the potential fates derived from ESCs, generating
mesoderm progenitors with cardiovascular, but not
hematopoietic, potential. Thus, in addition to its ef-
fects on EMT, Mesp1 may be capable of generating
the recently identified multipotent cardiovascular
progenitor from ESCs in vitro.
INTRODUCTION
Differentiating ESCs approximate the gastrulating epiblast
(Keller, 2005; Nishikawa et al., 2007; Wobus et al., 1991; Sakurai
et al., 2006; Yamashita et al., 2000). Canonical Wnt/b-catenin
signaling is required for gastrulation and mesoderm formation
in vivo (Liu et al., 1999; Huelsken et al., 2000) and for ESC differ-
entiation toward mesoderm-derived lineages (Lindsley et al.,
2006). In the current study, we performed a functional screen
in ESCs to identify Wnt-dependent transcription factors that
could induce Wnt-independent development of mesoderm-
derived lineages.
Mesp1 is a basic helix-loop-helix transcription factor that is
transiently expressed by the earliest progenitors of the cardio-
vascular system from E6.5 to E7.5 (Saga et al., 2000). Lineage
tracing studies show that virtually all cells of the heart and cellsof the vascular system derive from Mesp1-expressing precur-
sors (Saga et al., 2000). During gastrulation, progenitors of car-
diogenic mesoderm arise at E6.5 in the posterior lateral epiblast
and migrate to form the cardiac crescent at E7.5, when regional-
ized cell fates are first delineated (Meilhac et al., 2004; Lawson
et al., 1991; Tam et al., 1997). Lineage tracing and heterotopic
transplantation studies suggest that precursors in the earliest
heart field possess potential to generate myocardium, endocar-
dium, and epicardium, but subsequently become restricted as
lineage-specific regulatory programs are activated (Kitajima
et al., 2000; Tam et al., 1997). The mechanisms by which induc-
tive signals in the primitive streak influence development of the
cardiac progenitor field are incompletely understood (Kelly,
2005).
In this study, we report thatMesp1 induces features of EMT in
differentiating ESCs and promotes development of mesoderm
precursors of the cardiovascular lineage. The induction of EMT
is likely a result of the ability of Mesp1 to induce Snai1, which
we show can independently decrease E-Cadherin. Further, we
show that transient expression of Mesp1 is sufficient to allow
development of cardiovascular mesoderm, including endothelial
cells, smooth muscle cells, and cardiomyocytes, while inhibiting
development of other mesodermal lineages, correlating with
changes in global gene expression induced by Mesp1. Finally,
Mesp1 induces maximal cardiac Troponin T (cTnT) expression
with inhibition of Wnt signaling, corresponding with the inhibition
of cardiac development by Wnt signaling at later stages
in vivo (Schneider and Mercola, 2001; Ueno et al., 2007). These
results suggest that Mesp1 is sufficient for triggering EMT and
programming nascent mesoderm toward a restricted set of
cardiovascular fates.
RESULTS
Mesp1 Induces Wnt-Independent Expression
of Mesodermal Markers
We previously identified transcription factors whose expression
during early ESC differentiation requiredWnt signaling, many be-
ing associated with the primitive streak or mesoderm (Lindsley
et al., 2006). Among these were Brachyury (T), Mixl1, Evx1,Cell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc. 55
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Mesp1 Initiates Cardiovascular DifferentiationFigure 1. Mesp1 Induces Wnt-Independent
Development of Flk1+ Mesoderm
(A) A2lox ESCs, or A2lox cells targeted with the in-
dicated cDNAs, were treated with both DKK1 and
dox between days 2 and 4 of differentiation. On
day 4, cells were analyzed by flow cytometry for
Flk1 and PDGFRa expression. Numbers indicate
the percentage of live-gated cells within each
quadrant.
(B) A2lox.Mesp1 ESCs were differentiated in the
absence (No Treatment) or presence (+ DKK1) of
recombinant DKK1 from days 2–4 of differentia-
tion, either with (+ dox) or without ( dox) doxycy-
cline from days 2–4 of differentiation. Cells were
analyzed at the indicated times as in (A).Eomes, Mesp1, Cdx2, and Hand1. We hypothesized that some
of these factors might induce mesoderm development indepen-
dently of Wnt activity. To test this, we generated ESC lines with
doxycycline (dox)-inducible expression of each candidate. We
analyzed PDGFRa and Flk1 expression (Sakurai et al., 2006;
Tada et al., 2005) for each candidate line after ESC differentiation
in the presence of DKK1, with dox treatment from day 2 to day 4
(Figure 1A). Of the candidates tested, Mesp1 most markedly
increased the frequency of PDGFRa+ and Flk1+ cells. After 2
days of Mesp1 expression, only 4% of cells failed to express
Flk1 or PDGFRa, whereas the majority of cells were PDGFRa
Flk1 for all other candidates. Thus, Mesp1 robustly induces
early mesoderm markers independently of Wnt signaling.
During ESC differentiation, endogenous Mesp1 mRNA was
detected on day 2.5, was maximal on days 3 to 3.5, and was
nearly extinguished by day 4.5 (Figure S1A). We generated an
A2lox ESC line with inducible V5-epitope-tagged Mesp1
(Figure S1C). Upon differentiation, V5-
Mesp1 protein was not detected unless
cells were treated with dox. After dox ad-
dition on day 2 and medium replacement
on day 4, Mesp1 protein was detectable
only on days 3 and 4, accurately reflecting
the expression of endogenous Mesp1. In
A2lox cells expressing either a Mesp1-
GFP fusion protein or a bicistronic
Mesp1-ires-GFP message (Figure S1E,
upper panels), doxycycline induced
uniform GFP expression in 88.2% and
95.6% of cells, respectively, indicating
expression in all cells and at similar levels.
Thus, we used these same conditions
and timing of Mesp1 induction (i.e., add-
ing dox from day 2 to 4) (Figure S1B) for
the following studies.
We analyzed Flk1 and PDGFRa
expression in differentiating A2lox.Mesp1
cells at various times (Figure 1B; Table
S4). In unmanipulated cultures, differenti-
ating ESCsdeveloped into Flk1PDGFRa+
(13%), Flk1+PDGFRa+ (10%), and
Flk1+PDGFRa (4%) populations on day 4 of differentiation,
which increased to 34%, 24% and 6% on day 5, respectively
(Figure 1B, Table S4). None of these populations developed in
the presence of DKK1 alone, consistent with a Wnt requirement
by early mesoderm (Lindsley et al., 2006; Kelly et al., 2004). In
the presence of DKK1, Mesp1 induced development of
Flk1PDGFRa+ cells to 77% after one day (Figure 1B, day 3),
followed by an increase in Flk1 expression on days 4 and 5
(Figure 1B). Bromodeoxyuridine (BrdU) incorporation was
similar between untreated and dox-treated cultures
for both the Flk1PDGFRa+ and Flk1+PDGFRa+ populations
(Figure S1D) and both the Flk1PDGFRa+ and Flk1+PDGFRa+
populations expressed similar levels of Mesp1
(Figure S1E, lower panels). This suggests that these two
populations do not result from variable proliferative responses
to dox, but instead are induced sequentially after Mesp1
expression.56 Cell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc.
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Mesp1 Initiates Cardiovascular DifferentiationMesp1 Induces Wnt-Independent Genetic Changes
Associated with Epithelial-Mesenchymal Transition
Since Mesp1/ embryos showed altered cell migration during
gastrulation (Saga et al., 1999), we tested if Mesp1 might influ-
ence aspects of EMT, such as the switch from E-cadherin to
N-cadherin expression (Peinado et al., 2004; Shook and Keller,
2003; Moustakas and Heldin, 2007) (Figure 2A). On day 4, un-
treated differentiating ESCs show a typical heterogeneous
pattern of nonoverlapping regions of E-cadherin or N-cadherin
expression (Figure 2A). DKK1 treatment causes uniform mainte-
nance of E-cadherin expression and loss of N-cadherin induction
(Figure 2A). Mesp1 completely inhibited E-cadherin and uni-
formly induced N-cadherin expression, either with or without
DKK1 treatment (Figure 2A). We next determined the changes
in global gene expression induced by Mesp1 (Figure 2B).
A2lox.Mesp1 ESCs were differentiated for 48 hr, were induced
with dox both in the absence and presence of DKK1, and were
analyzed 6, 12, 24, 48, 96, and 120 hr after dox addition (Table
S1). In the presence of DKK1, Mesp1 inhibited expression of
several epithelial genes, including claudin 3 (Cldn3), claudin 7
(Cldn7), occludin (Ocln), and E-cadherin (Cdh1) within 24 hr of in-
duction (day 3), with further inhibition on day 4 (Figure 2B). At the
same time, Mesp1 induced expression of many mesenchymal
genes, including matrix metallopeptidase 2 (Mmp2), vimentin
(Vim), N-cadherin (Cdh2), and fibronectin (Fn1). These results
suggest Mesp1 induces a global transition from epithelial to
mesenchymal gene expression.
Next we examined transcription factors that regulate EMT,
such as snail (Snai1) and twist (Twist) (Carver et al., 2001; Thiery
and Sleeman, 2006). In the presence of DKK1, Mesp1 induced
Snai1 and Twist expression within 24 hr (Figure 2B). Snai1 ex-
pression increased progressively from 5-fold induction at 6 hr
to 39-fold induction after 24 hr of dox treatment (Figures 2C
and 2D). To test if Snai1 could mediateMesp1’s actions, we gen-
erated a dox-inducible A2lox.Snai1 ESC line and examined
E-cadherin repression by Snai1 or Mesp1 (Figure 2E). Both
Mesp1 and Snai1 decreased E-cadherin expression, by 59%
and 52% respectively. However, unlike Mesp1, Snai1 failed to
induce Flk1+ or PDGFRa+ expression in DKK1-treated cultures
(Figure 2F), suggesting that Snai1 can mediate some, but not
all, of Mesp1’s actions.
To ask if Mesp1 is necessary for EMT or for Snai1 expres-
sion in ESCs, we used mice with Cre recombinase targeted
to the Mesp1 locus (Mesp1Cre/+) (Saga et al., 1999) to generate
ESCs that were Mesp1 heterozygous (Cre/+) or Mesp1 defi-
cient (Cre/Cre) (Figure 2G). After 5 days of differentiation in un-
manipulated cultures, Mesp1Cre/Cre cells retained endogenous
Snai1 expression (Figure 2H), had downregulated E-cadherin,
and upregulated N-cadherin, indicating an EMT similar to con-
trol Mesp1Cre/+cells (Figure 2I). Interestingly, the Mesp1Cre/Cre
cells expressed a related family member Mesp2 at a slightly in-
creased level compared to Mesp1Cre/+cells (Figure 2H). Since
Mesp2 can compensate for migratory defects in Mesp1-defi-
cient embryos (Kitajima et al., 2000), we asked if Mesp2 can
induce mesoderm and EMT in ESCs (Figure S2). Dox treatment
of A2lox.Mesp2 cells induced expression of Flk1 and PDGFRa
(Figure S2A), downregulated E-cadherin (Figure S2A), and in-
duced Snai1 expression in DKK treated cultures (Figure S2B).
Thus, the ability of differentiating Mesp1-deficient ESCs toexpress Snai1 and undergo EMT may be due to compensation
byMesp2.
Mesp1 Induces a Restricted Subset of Mesodermal
Gene Expression
At 96 hr after induction of Mesp1, global microarray expression
data identified four gene expression patterns roughly correlating
with distinct cell lineages (Figure 3A; Table S1). One set of genes
was inhibited by Mesp1 but was also inhibited by Wnt signaling
(Figure 3A, NEURO). These genes were only expressed in the
presence of DKK1, but then were inhibited byMesp1 in this con-
dition, and contained genes such as Sox2 and Pax6, which are
associated with neuroectoderm, and Pax7, which is associated
with neuroectoderm and paraxial mesoderm. This expression
pattern observed by microarray was also confirmed by RT-
PCR (Figure 3B). A second set of genes was inhibited by
Mesp1 but required Wnt signaling for expression (Figure 3A,
HEME). These genes were only expressed in the absence of
DKK1, but then were inhibited by Mesp1 in this condition, and
contained many genes that were associated with the hemato-
poietic lineage (D’Souza et al., 2005), such as Tal1, Gata1, and
Hbb-b1 (Figure 3C). A third set of genes was induced by
Mesp1, but only during inhibition of Wnt signaling (Figure 3A,
CARDIOMYOCYTE). These genes were only expressed in the
presence of both DKK1 and Mesp1 and contained many genes
that were cardiomyocyte specific, such as Myh6, Myh7, Myl2,
Myl7, Tnnt2, and Nppa (Figure 3D) (Yuasa et al., 2005). A fourth
set of genes was induced by Mesp1, but their endogenous ex-
pression required Wnt signaling (Figure 3A, ENDOTHELIAL,
SMC). These genes were inhibited by DKK1, but were induced
by Mesp1 in this condition, and contained many genes associ-
ated with endothelial and smooth muscle cells (Lindskog et al.,
2006), such as Tie1, Tek and Cdh5 expressed by endothelial
cells, and Acta2, Rgs5 and Pdgfrb expressed by smooth muscle
cells (Figures 3E and 3F). These results are summarized in
Figure 3G and are consistent with Mesp1 lineage tracing of car-
diovascular cells in vivo (Saga et al., 2000).Mesp1 is expressed
in lateral mesoderm, the origin of cardiovascular lineages, and in
paraxial (presomitic) mesoderm (Saga et al., 1999; Takahashi
et al., 2005, 2007). We asked ifMesp1 regulated paraxial meso-
derm gene expression (Figure S3). Mesp1 induced the paraxial
mesoderm genes Pax3 and Tcf15 on day 4, but this was not sus-
tained at day 6 (Figures S3A and S3B). Mesp1 failed to induce
other paraxial mesoderm genes, such as Mesp2, Tbx6, or Pax1
(Sakurai et al., 2006) (Figure S3C), or skeletal myogenic tran-
scription factors Myod, Myogenin, or Myf5 (Figures S3A and
S3B) (Rohwedel et al., 1995). However, this could either be
due to the inability of Mesp1 to induce paraxial genes or to
a bias against paraxial gene expression in the culture conditions.
Mesp1 Induces Differentiation of Either Smooth Muscle
Cells or Cardiomyocytes, Contingent on Wnt Activity
We used FACS and immunohistochemistry for a-smooth muscle
actin (aSMA, Acta2) and cardiac troponin T (cTnT, Tnnt2) to
quantify commitment to cardiovascular lineages in response to
Mesp1. aSMA is expressed by mesenchymal cells (Ball et al.,
2007), smooth muscle cells (Kattman et al., 2006), and embry-
onic cardiomyocytes (Ruzicka and Schwartz, 1988), and cTnT
is expressed in both embryonic and adult cardiomyocytesCell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc. 57
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Mesp1 Initiates Cardiovascular DifferentiationFigure 2. Mesp1 Expression Is Sufficient to Induce Wnt-Independent Epithelial to Mesenchymal Transition
(A) A2lox.Mesp1 cells differentiated as described in Figure S1B were plated on day 2 onto Collagen I-coated slides and stained with antibodies to E-cadherin
(green) and N-cadherin (red) on day 4. Nuclei were stained using Hoechst 33342 (blue).
(B) A2lox.Mesp1 cells were differentiated in the presence of DKK1, either with or without dox addition at day 2. On day 3 or day 4, gene expression was analyzed
using Mouse Genome 430 2.0 arrays (Affymetrix). Shown are log2 fold change of expression of the indicated genes on day 3 (gray bar) and day 4 (black bar).
Genes are arranged according to their association with either epithelial or mesenchymal phenotypes.58 Cell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc.
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Mesp1 Initiates Cardiovascular Differentiation(Jin et al., 1996; Cooper and Ordahl, 1985). On day 6 of differen-
tiation, untreated A2lox.Mesp1 ESCs contained a 4%population
of cells expressing aSMA (Figure 4A, Table S5). Without DKK1
treatment, Mesp1 increased aSMA expression to 45% of cells
(Figure 4A Table S5). cTnT was not expressed by untreated cul-
tures, consistent with a report that embryoid bodies in suspen-
sion cultures do not efficiently differentiate into cardiomyocytes
spontaneously (Ueno et al., 2007). Mesp1 did not induce cTnT
without DKK1 treatment. However, with DKK1, Mesp1 induced
a population of aSMA+ cTnT+ cells, and in this condition, the ma-
jority of cell clusters were spontaneously contractile (Figure S5).
We confirmed these results by fluorescence microscopy for
aSMA, smooth muscle myosin heavy chain (SM-MHC), and
cTnT expression (Figure 4B). On day 8, aSMA-expressing cells
were present in untreated cultures, increased byMesp1, and de-
creased by DKK1 treatment (Figure 4B). aSMA-expressing cells
were also induced by Mesp1 in the presence of DKK1. Cultures
with aSMA-expressing cells also contained a small number of
SM-MHC-positive cells (Figure 4B). RT-PCR analysis confirmed
the expression of SM-MHC (Myh11) and the smooth muscle
marker SM22, which had similar expression patterns to that of
SMA (acta2) (Figure S2D). cTnT was induced by Mesp1 in the
presence of DKK1 and, again, largely colocalized with aSMA
(Figure 4B).
We examined the maturity ofMesp1-induced cells by measur-
ing calcium fluxes and by voltage-clamp recording. The A7R5
vascular smooth muscle cells fluxed calcium in response to
vasopressin and ionomycin, but not angiotensin, as described
(Filipeanu et al., 2001). Mesp1-induced ESCs fluxed calcium in
response to ionomycin, but not vasopressin or angiotensin
(Figure S4), suggesting thatMesp1-induced a-SMA+ cells repre-
sent immature smooth muscle cells at this time. We next com-
pared whole-cell current and voltage-clamp recordings from
cultures induced by Mesp1 in the presence of DKK1 to those
from cultures treated with DKK1 only (Table S3). The mean rest-
ing membrane potential (Vm) measured in Mesp1-induced clus-
ters was significantly more hyperpolarized than the mean Vm of
cells treated with DKK1 alone (Table S3). Action potentials could
be evoked in some beating clusters obtained by Mesp1 induc-
tion in the presence of DKK1 (Figure 4C) and were more readily
evoked, larger in amplitude, and broader when outward K+ cur-
rents were blocked (Figure 4C, right panel) but were never
observed in cells treated with DKK1 alone. Voltage-gated out-
ward K+ currents (IK) and inwardly rectifying K
+ currents (IK1)
were recorded in all (n = 7) spontaneously beating clusters(Figure 4D). Although K+ currents were also detected in cells
treated with DKK1 alone, mean IK and IK1 densities were signifi-
cantly larger in clusters obtained byMesp1 induction in the pres-
ence of DKK1 (Table S3). Voltage-gated inward currents were
also evident in some recordings (n = 2) (Figures 4D and 4E, left
panels), and inward Na+ (INa) and Ca
2+ (ICa) currents (Figures
4D and 4E, right panels) could be measured only in Mesp1-
induced cells (Table S3). These results show that spontaneously
beating clusters induced byMesp1 in the presence of DKK1 are
electrically differentiated compared to cultures treated with
DKK1 alone and are consistent with an early stage of differenti-
ation into cardiomyocytes (Nerbonne and Kass, 2005). The
selective cTnT expression induced by Mesp1 with DKK1 is
consistent with known effects of Wnt signaling on cardiac devel-
opment, in which Wnt signaling is required for early steps but is
inhibitory at later stages of cardiac development (Ueno et al.,
2007; Naito et al., 2006).
Because aSMA and cTnT expression did not account for all
cells responding to Mesp1, we asked if endothelial markers
were induced byMesp1 (Figures 5A and 5B). Untreated cultures
had abundant Pecam1+ cells (Figure 5A), consistent with a previ-
ous report (Yamashita et al., 2000), but these were lost upon
DKK1 treatment. Mesp1 restored Pecam1+ expression in
DKK1-treated cultures (Figure 5A). Pecam1+ cells also ex-
pressed the endothelial marker VE-cadherin (Figure 5B). Thus,
Mesp1 may induce a progenitor of cardiomyocytes, smooth
muscle, and endothelial cells, with the fate selected by this pro-
genitor depending on other signals, such as Wnt, as suggested
by the promotion of cardiomyocyte development by DKK1.
Mesp1 Inhibits Hematopoietic Potential of ESCs In Vitro
and Is Expressed by Only a Small Percentage
of Hematopoietic Progenitors In Vivo
We asked ifMesp1 functionally inhibited hematopoietic compe-
tence of differentiating ESCs (Figure 5C). Development of prim-
itive and definitive hematopoietic colonies (Kyba et al., 2003)
was inhibited by DKK1 (Figure 5C) as described (Lindsley
et al., 2006).Mesp1 failed to restore hematopoietic competence
in DKK1-treated differentiating ESCs and eliminated primitive
and definitive hematopoietic colonies in the absence of DKK1
(Figure 5C). However, these results do not distinguish active in-
hibition of hematopoietic development from skewing ES cultures
toward cardiovascular development.
Successive populations of Flk1+ cells arise during ESC differ-
entiation that contain either hematopoietic or cardiovascular(C)Snai1 gene expression analysis at 6, 12, and 24 hr afterMesp1 induction. A2lox.Mesp1 cells were differentiated as in (B) andwere harvested 6, 12, or 24 hr after
dox addition, and gene expression was analyzed as in (B). Shown is the fold increase of Snai1 expression in cells treated with DKK1 and dox compared to time-
matched controls treated with DKK1 only.
(D) Snai1 andGapdh expression were measured on day 3 of differentiation by RT-PCR. A2lox.Mesp1 ESCs were differentiated in the absence (NT) or presence of
DKK1 (DKK1) beginning at day 2, either without () or with (+) addition of dox at day 2.
(E) A2lox.Mesp1 and A2lox.Snai1 ESCs differentiated as in (D) were analyzed on day 4 for E-cadherin levels by flow cytometry. Shown are histogram overlays of
E-cadherin staining for each cell line treated with DKK1 alone (green) and DKK1 plus dox (red). Numbers represent the frequency of live-gated cells found within
the indicated gates (G1 or G2) for DKK-treated (green) or DKK and dox-treated (red) cells.
(F) A2lox.Mesp1 and A2lox.Snai1 ESCs were treated with both DKK1 and dox. Cells were harvested on day 4 and analyzed by flow cytometry as in Figure 1.
(G) Mesp1 heterozygous or Mesp1-deficient ESCs were derived from blastocysts of crosses between Mesp1cre/+ heterozygous knockin mice. Heterozygous
(Cre/+) or Mesp1-deficient (Cre/Cre) ESCs and wild-type (+/+) or heterozygous (Cre/+) mice were genotyped by PCR.
(H)Mesp1,Mesp2,Snai1, andGapdh expression in heterozygous (Cre/+) orMesp1-deficient (Cre/Cre) cells weremeasured byRT-PCRonday 5 of differentiation.
(I)Mesp1 heterozygous (green) orMesp1-deficient (blue) ESCs, differentiated as embryoid bodies, were harvested on day 5. E-cadherin and N-cadherin levels,
determined by flow cytometry, were compared to levels on DKK-treated cultures (shaded).Cell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc. 59
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Mesp1 Initiates Cardiovascular Differentiationprogenitors (Kattman et al., 2006). To test if Mesp1-expressing
Flk1+ cells could contribute to the hematopoietic system
in vivo, we extendedMesp1 lineage tracing to the hematopoietic
Figure 3. Mesp1 Induces Expression of a Re-
stricted Subset of Mesoderm-Associated Genes
(A) A2lox.Mesp1 ESCs were differentiated in the absence
(NT) or presence (DKK1) of DKK1, either without () or with
(+) addition of dox from days 2 to 4. On day 6, gene ex-
pression was analyzed bymicroarray analysis. Normalized
sample data were evaluated for 5-fold changes following
Mesp1 induction: (NT+ dox versus NT) or (DKK1+ dox
versus DKK1). Representative clusters of the indicated
lineage-specific genes are shown as heat maps with red
shading indicating increased expression and blue shading
indicating decreased expression.
(B–F) Cells differentiated as in (A) were harvested at day 6
(C, E, and F) or day 8 (B and D), and expression of the
indicated genes was analyzed by RT-PCR.
(G) Results described in ([A]–[F], and Figures 2A–2D) are
shown schematically. ESC, embryonic stem cell; EB, em-
bryoid bodies; EMT, epithelial mesenchymal transition.
system (Figure 5D). We analyzed GFP expres-
sion in hematopoietic progenitor cells and ma-
ture blood cells isolated from adult Mesp1-Cre
(Mesp1Cre/+) mice (Saga et al., 1999) crossed
to the Cre-reporter mouse strain R26R-eGFP
(Rosa26R26ReGFP/+) (Figure 5D). In Mesp1+/+
R26R-eGFPmice, no GFP+ blood cells were ob-
served, as expected. In Mesp1+/Cre R26R-eGFP
mice, the majority (>96%) of hematopoietic cells
were negative for GFP, but a small population of
GFP+ cells was reproducibly present in hemato-
poietic cells of thesemice. GFP+ cells comprised
1.3%of lineageneg cKithi bonemarrowprogenitor
cells (1.2% of the total gate), 2.8% of GR1+ bone
marrow granulocytes (2.2% of the total gate),
2.8% of CD19+ splenic B cells (1.8% of the total
gate), and 2% of CD3+ splenic T cells (1% of the
total gate) (Figure 5D). Thus, during embryogen-
esis, Mesp1-expressing cells are largely ex-
cluded from the hematopoietic mesoderm,
consistent with our in vitro results (Figure 5C).
Mesp1 Induces Stable Expression
of Cardiovascular Transcription Factors
Mesp1 could induce cardiovascular mesoderm
either by restoring Wnt-dependent primitive
streak gene expression or by directly specifying
a cardiovascular progenitor. Thus, we examined
expression of primitive streak-associated genes
and core cardiac transcription factors (Srivas-
tava, 2006) after Mesp1 induction (Figure 6A).
T (brachyury), MixL1, and endogenous Mesp1
were expressed in control cultures on day 3
and day 4 of differentiation, markedly inhibited
by Mesp1 induction, not expressed in DKK1-
treated cultures and not restored by Mesp1
(Figure 6A). Thus,Mesp1 does not appear to re-
store primitive streak-associated gene expression. In contrast,
Gata4, Foxc1, Foxc2, and Isl1, transcription factors which act
in the first and second heart fields (Srivastava, 2006), were60 Cell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc.
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Mesp1 Initiates Cardiovascular DifferentiationFigure 4. Mesp1-Induced Expression of Cardiac Troponin T Requires Blockade of Wnt Signaling
(A) A2.Mesp1 ESCs were differentiated with (+ dox) or without ( dox) dox and left without DKK1 treatment (No Treatment) or treated with the DKK1 from day 2–6.
On day 6, cells were fixed, permeabilized, and stained with FITC-anti-aSMA,mouse-anti-cTnT, and APC-anti-mouse Ig. The numbers shown indicate the percent
of live cells present within the indicated region.
(B) A2.Mesp1 ESCs were differentiated as in (A) and plated on Collagen I-coated slides on day 4 or day 7 (SMM-HC). On day 8, cells were stained with antibodies
to aSMA (green), cTnT (red), and SM-MHC (green, bottom panel). Nuclei were stained using Hoechst 33342 (blue). Representative images are shown, where the
scale bar is 200 mm (aSMA/cTnT) or 50 mm (SM-MHC).
(C–E) Action potentials and ionic currents were recorded from spontaneously beating clusters in DKK+dox cultures on day 10.Whole-cell action potentials (C) and
macroscopic currents (D) were recorded with K+- (left panels) or Cs+-containing (right panels) pipette solution (D) In voltage-clampmode, currents were evoked in
response to a series of 300 ms voltage steps (120 to +40 mV) from the holding potential of70 mV; the dotted lines indicate the zero current level. Insets show
inward currents evoked by depolarizing steps from40 to +10mV at a higher gain. (E) Peak (filled circles) and plateau (empty circles) current densities are plotted
as a function of the test potential.induced by Mesp1 with or without DKK1 (Figures 6B and 6C).
Tbx1, a factor regulated by forkhead proteins in the second heart
field (Maeda et al., 2006), was detected only in Mesp1-induced
cultures (Figure 6B). Mesp1 also induced Zfhx1a, implicated in
smooth muscle differentiation (Nishimura et al., 2006) and
myocardin (Myocd), important for smooth muscle and cardio-
myocyte differentiation (Li et al., 2003) (Figure 6B; Table S1).
Moreover, the transcription factors Gata4, Gata6, Hand1,
Hand2, Mef2c, Smyd1 (Bop), Tbx5, and Tbx20 were all inducedby Mesp1 and were maintained for at least 8 days after dox re-
moval (Figure 6C). Endogenous expression of these genes was
inhibited by DKK1, and their expression was induced by
Mesp1 in the presence of DKK1.
Since Mesp1 induced cTnT only with DKK1 treatment (Fig-
ures 4A and 4B), we asked if any transcription factors were
induced preferentially with DKK1. Nkx2-5 was more strongly
induced byMesp1 in the presence of DKK1 (Figure 6D), consis-
tent with microarray data (Figure 3A), which was confirmed atCell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc. 61
Cell Stem Cell
Mesp1 Initiates Cardiovascular DifferentiationFigure 5. Mesp1 Expression Induces Endothelial Differentiation and Inhibits Hematopoietic Potential of Differentiating ESCs
(A and B) A2lox.Mesp1 ESCs were differentiated as in Figure S1B and were plated on Collagen I-coated slides on day 4 of differentiation. On day 12, cells were
stained with antibodies to Pecam1 (green) and VE-cadherin (red) as indicated. Nuclei were stained using Hoechst 33342 (blue). (A) Representative images are
shown where the scale bar is 200 mm. (B) Higher power image (scale bar, 50 mm) of culture treated with both DKK1 (day 2–6) and dox (day 2–4). (C) A2lox.Mesp1
ESCs were differentiated as in Figure S1B. On day 6, cells were assessed for hematopoietic precursor potential using methycellulose colony forming assays.
Primitive erythroid (black) and definitive hematopoietic (gray) colonies were counted at days 12 and 16, respectively. (D) Cells were obtained from adult Rosa
R26R-eGFP+/mice that were either Mesp1+/+ or Mesp1Cre/+. Bone marrow cells were analyzed by flow cytometry for GFP expression in cKithi lineage live cells
or Gr1+ cells contained in a granulocyte live-cell gate. Splenocytes were analyzed for GFP expression in either CD19+ or CD3+ cells contained in a lymphocyte live
gate. Numbers shown are the percentage of live-gated cells in each quadrant.the level of protein by western analysis (Figure 6E). Although
Gata4 was expressed in untreated cultures and dox-treated
cultures, was inhibited by DKK1, and was induced by Mesp1
in the presence of DKK1, Nkx2.5 was much more strongly in-
duced by Mesp1 in cultures treated with DKK1 compared to
non-DKK1-treated cultures (Figure 6E), consistent with RT-PCR
results (Figure 6D). In summary, the induction byMesp1 of multi-
ple cardiogenic transcription factors, but not primitive streak-,
hematopoietic-, or paraxial mesoderm-associated genes,
suggests that Mesp1 might selectively program cardiovascular
development.62 Cell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc.Identification of Early Transcriptional Targets
of Mesp1 Activity
We used reporter analysis to ask if Nkx2.5 orMyocd were direct
targets ofMesp1 (Figure S6A). Activation of the EphA4 enhancer
required both Mesp1 and E47, as expected (Nakajima et al.,
2006). However, cardiac-specific enhancers for Nkx2.5 (Searcy
et al., 1998) and Myocd (Creemers et al., 2006) were not acti-
vated by cotransfection of Mesp1 alone or with E47, indicating
they may not be direct targets of Mesp1. However, other en-
hancer regions ofNkx2.5 (Lien et al., 1999) orMyocdmight be re-
sponsive toMesp1, or other factors not present in 293T cellsmay
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Mesp1 Initiates Cardiovascular Differentiationbe required in order forMesp1 to act. Since directMesp1 targets
should be induced earlier than indirect targets, we characterized
Mesp1-induced gene expression after 6, 12, and 24 hr of dox
treatment on day 2 of differentiation in DKK1-treated cultures
(Figure 7A; Table S1). After 6 hr, 41 genes were induced
>3-fold; after 12 hr, 152 genes were induced; and after 24 hr,
>500 genes were induced (Figure 7A). Nearly 1/3 of genes
induced by Mesp1 after 12 hr were regulators of transcription
or signaling and included the transcription factors Foxc1,
Foxc2, Cited1, and Zfhx1b, which were induced within 6 hr
(Table S1).
Figures S6B and S6C show the fold changes in expression of
transcription factors and signaling molecules induced byMesp1
in the presence of DKK1 after 12 hr. Mesp1 inducedmany genes
relevant to EMT and development of cardiovascular lineages
in vivo. Snai1 and Lhx1, related to EMT (Carver et al., 2001;
Hukriede et al., 2003), were induced 6 hr after dox addition.
Gata2, which promotes endothelial cell development and inhibits
hematopoietic development from multipotent progenitors
(Persons et al., 1999; Minegishi et al., 2003; Lugus et al., 2007),
was induced 5-fold by 6 hr and 14-fold by 12 hr after dox treat-
ment. A number of Wnt-related factors were induced by Mesp1
(Table S1). Wnt5a, which acts in the noncanonical Wnt
pathway important in several models of cardiogenesis (Eisen-
berg and Eisenberg, 2006; Fraidenraich et al., 2004), was
induced 55-fold and 93-fold at 6 and 12 hr after dox addition, re-
spectively. DKK1, recently proposed as a direct target ofMesp1
(David et al., 2008), was induced 50-fold by Mesp1 in the pres-
ence of DKK1, but not until 24 hr after dox addition (Table S1).
Notably, Myocd, a coactivator which regulates serum response
factor (SRF) andMef2c activity during embryogenesis and which
activates smoothmuscle and cardiac gene expression programs
in vitro and in vivo (Pipes et al., 2006; Du et al., 2003), was
induced 74-fold by Mesp1 in DKK1-treated cultures after 24 hr.
Myocardin Activity Is Required for Mesp1 Induction
of cTnT+aSMA+ Cardiomyocytes and cTnTaSMA+
Smooth Muscle Cells
A dominant-negative form ofMyocardin (Myocd) lacking a trans-
activation domain inhibits cardiogenesis in Xenopus embryos
(Wang et al., 2001). Myocd/ murine embryos show disruption
of vascular smooth muscle, but not cardiac development
(Li et al., 2003), suggesting other members of the myocardin-re-
lated transcription factor (MRTF) family besides Myocd might
function in murine cardiac development. To test if Myocd is im-
portant for Mesp1-induced cardiovascular differentiation, we
developed an inducible dual-expression system to allow simul-
taneous induction of Mesp1 and dominant-negative Myocd
(Figure 7B). We first confirmed that this system can inducibly
coexpress two different cDNAs (Figure S7). In A2lox.GFP-RFP
cells, GFP and RFP were both induced upon dox treatment,
but not in the absence of dox, indicating this system allows for
coinduction by dox of two cDNAs. We examined the effect of
dominant-negative (DN)Myocd onMesp1 induction of themeso-
derm markers PDGFRa and Flk1. Mesp1 increased the fre-
quency of PDGFRa+ and Flk1+ cells, both in the absence and
presence of DKK1 (Figure 7B, top row). Expression of DN-Myocd
alone, withoutMesp1, did not change the frequency of PDGFRa+
or Flk1+ cells in the absence of DKK1 and failed to induce these
populations in the presence of DKK1 (Figure 7B, middle row).
Coexpression of DN-Myocd, along with Mesp1, did not alter
the frequency of PDGFRa+ or Flk1+ cells induced by Mesp1
either in the absence or presence of DKK1 (Figure 7B, bottom
row). Thus, induction by Mesp1 of the mesoderm markers
PDGFRa and Flk1 is independent of Myocd.
Figure 6. Mesp1 Activates Stable Expression of the Core Regulatory
Network of Cardiomyogenic Transcription Factors
(A–D) A2lox.Mesp1 ESCs were differentiated as in Figure S1B. Cells were har-
vested on days 3, 4, 6, 8, and 12, and expression of the indicated genes was
analyzed by RT-PCR.
(E) A2lox.Mesp1 ESCs, differentiated as indicated in Figure S1B, were har-
vested on day 6. Expression of the indicated proteins was analyzed bywestern
blotting (see the Supplemental Experimental Procedures).Cell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc. 63
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Mesp1 Initiates Cardiovascular DifferentiationFigure 7. Mesp1 Rapidly Induces Expression of Many Genes, Including Myocardin, which Is Required for Differentiation of Cardiomyocyte
and SMC Lineages
(A) A2lox.Mesp1 ESCs were differentiated in the presence of DKK1 without dox (Control) or with addition of dox (Mesp1) at day 2. Gene expression was assessed
by microarray analysis at the indicated times (hrs) after doxcycyline addition. Normalized expression values were compared for 3-fold changes between time-
matched samples that were either untreated or treated with dox. 592 genes satisfying the comparison criteria are shown using hierarchical clustering analysis.
(B and C) A2lox.Mesp1 ESCs containing inducibleMesp1 (Mesp1), A2lox.Myocd DN ESCs containing inducible DNmyocardin (D585) lacking the transactivation
domain (DN Myocardin) (Wang et al., 2001), and A2lox.Mesp1-Myocd DN ESCs containing simultaneously inducible Mesp1 and DN myocardin (Mesp1 + DN
Myocardin) were differentiated as in Figure S1B, and cells were harvested on day 4 (B) and day 6 (C). (B) Expression of PDGFRa and Flk1 was assessed by
flow cytometry as in Figure 1B. (C) Expression of aSMA and cTnT was assessed by flow cytometry as in Figure 4B. The numbers shown indicate the percent
of live cells present within each quadrant.We next examined the effect of DN-Myocd on Mesp1 induc-
tion of aSMA and cTnT (Figure 7C). Mesp1 alone induced
aSMA+cTnT cells and aSMA+cTnT+ cells in the absence and
presence of DKK1, respectively (Figure 7C, top row). DN-Myocd
alone slightly inhibited aSMAexpression (Figure 7C,middle row).
When coexpressed with Mesp1, DN-Myocd strongly inhibited
aSMA+cTnT cells, with DKK1 (30.8% to 5.3%) or without
DKK1 (40.2% to 13.9%) (Figure 7C, bottom row). Also, DN-My-
ocd inhibitedMesp1-induced development of aSMA+cTnT+ cells
in the presence of DKK1 (24.2% to 4.5%). These results are con-64 Cell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc.sistent with a role for Myocd in Mesp1-induced smooth muscle
cell and cardiomyocyte differentiation.
DISCUSSION
Identification of Mesp1 as a Transcription Factor
Sufficient for Wnt-Independent Mesoderm Induction
Mesp1 was identified in our screen as driving Wnt-independent
expression of mesoderm markers, but we found that it also in-
duces features of epithelial-mesenchymal transition (EMT) and
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lineages.Mesp1 initiates large-scale changes in global gene ex-
pression that evolved over time in contrast to limited changes in-
duced by other candidates (data not shown). Our approach
could fail to identify mesoderm-inducing factors that are ex-
pressed at low levels during ESC differentiation (Lindsley et al.,
2006) or that requireWnt signaling to inducemesoderm. A recent
study claimed that Mesp1 promotes cardiovascular differentia-
tion in ESCs by induction of DKK1 (David et al., 2008) but did
not examine Mesp1 in regulating Snai1 or EMT. Our study has
shown that the mechanism by which Mesp1 restricts the fate
of differentiating ESCs is not exclusively through induction of
DKK1, but likely involves more direct actions on induction or
suppression of many transcription factors as discussed below.
Correlation of In Vivo and In Vitro Actions
ofMesp1 and Mesp2 Activity
Mesp1 was cloned by subtractive hybridization from the poste-
rior primitive streak of 7.5 day embryos (Saga et al., 1996).
Mesp2, a closely related homolog located near the Mesp1
gene, was cloned by homology to Mesp1 (Saga et al., 1997).
Mesp1 is required for normal heart development, and Mesp1/
embryos display early lethality (Saga et al., 1999). In Mesp1/
mice in which bGal is targeted to the Mesp1 locus, bGal-ex-
pressing cells accumulate in the primitive streak (Saga et al.,
1999). However,Mesp1/ embryos do generate cardiac meso-
derm, although their heart tubes fail to fuse, leading to cardia
bifida and embryonic death (Saga et al., 1999). Mesp1/ em-
bryos also show increased and prolonged expression of
Mesp2 in the primitive streak, suggesting that Mesp2 may
compensate for migratory defects, but not for heart devel-
opment seen in Mesp1/ embryos (Kitajima et al., 2000). In
Mesp1/Mesp2/ double-deficient embryos, there is an
accumulation of nonmigrating cells in the primitive streak and
complete failure to form cardiac mesoderm (Kitajima et al.,
2000). Thus,Mesp1 andMesp2mayshare potential transcriptional
targets, consistent with finding common induction of Snai1, but
private functions may arise from expression at distinct sites
and times in the embryo, and verifying targets of Mesp1 in vivo
may require examination of Mesp1/Mesp2/ embryos.
Mesp1 and Generation of Cardiovascular Progenitors
Recent studies identified a multipotent Isl1+ cardiovascular pro-
genitor cell (MICP) in vivo that gave rise to endothelial, cardiac,
and smooth muscle cells (Moretti et al., 2006; Wu et al., 2006).
Cardiovascular colony-forming cells (CV-CFC) identified in dif-
ferentiating ESCs may represent this divergence between
cardiovascular and hemogenic lineages (Moretti et al., 2006;
Kattman et al., 2006). Our study suggests that Mesp1 may rep-
resent the transcriptional basis for development of the MICP
and CV-CFC and is consistent with a study suggesting that the
orthologous Ciona intestinalis gene Mesp specifies the cardio-
myocyte lineage independently of cell migration (Satou et al.,
2004; Davidson et al., 2005). Early transcriptional targets of
Mesp1 include Snai1 and Myocd, representing plausible links
to EMT and cardiovascular commitment, although we have not
determined whether these are direct Mesp1 targets.
Recent studies have found both positive and negative effects
of Wnt signaling in the proliferation (Kwon et al., 2007; Cohenet al., 2007; Ai et al., 2007) and the specification and differentia-
tion of cardiovascular progenitors (Lin et al., 2007; Ueno et al.,
2007; Naito et al., 2006; Kwon et al., 2007; Eisenberg and Eisen-
berg, 2006; Tzahor, 2007; Qyang et al., 2007). Our previous study
showed that development of Flk1+ mesoderm precursors,
including cardiovascular mesoderm, required Wnt signaling
(Lindsley et al., 2006). Our current findings suggest that the early
requirement for Wnt signaling on cardiovascular development
may stem from the Wnt-dependence of Mesp1 expression.
The inhibition by Wnt signaling of later cardiovascular differenti-
ation (Eisenberg and Eisenberg, 2006) would represent actions
of Wnt on the specified MICP (or its progeny) that influence
cardiac muscle or smooth muscle differentiation.
A recent study suggested thatMesp1 induced cardiovascular
differentiation in ESCs through induction of DKK1 (David et al.,
2008). That conclusion was based on a correlation of Mesp1’s
actions with the induction of DKK1 byMesp1. In this and a previ-
ous study (Lindsley et al., 2006), we have shown that treatment of
differentiating ESCs with DKKI actually inhibits mesoderm line-
age development. We suggest that the induction of cardiovascu-
lar fates byMesp1might derive instead from the rapid induction
of transcription factors that are targets of Mesp1 rather than in-
duction of DKK1. Identifying the mechanisms by which Mesp1
acts may be relevant to understanding cardiac development
and eventual applications to regenerative therapy.
EXPERIMENTAL PROCEDURES
ESC Generation and Differentiation
MC50 (Dr. Robert Schreiber, Washington University School of Medicine) and
modified A2lox ESCs (Kyba et al., 2002) were maintained as described (Linds-
ley et al., 2006). Individual cDNAs were amplified from embryoid body RNA us-
ing gene-specific primers (Table S2) and were cloned into the p2lox targeting
vector (Kyba et al., 2003). Site specific recombination into A2lox ESCs using
cotransfected Cre recombinase was as described (Lindsley et al., 2006; Kyba
et al., 2003). An inducible, dual-expression vector was prepared by cloning
a cDNA (either GFP or DNMyocd [aa 1–585] [Wang et al., 2001]) into the vector
pTet-CMVmin pA-zeocin (Dr. Jonathan Green,Washington University School of
Medicine), transferring this Tet-CMVmin promoter-cDNA-pA cassette into the
p2lox targeting vector downstream of the original p2lox pA site, and followed
by inserting a second cDNA (either RFP or Mesp1) into the resulting plasmid,
allowing simultaneous dox induction of both cDNAs in transfected A2lox ESCs.
For differentiation, ESCs were plated in suspension in Petri dishes at 1.5 3
104 cells/ml in Iscove’s modified Dulbecco’s medium with 10% FCS, NEAA,
L-glutamine, NaPyruvate, Pen/Strep, and 2-mercaptoethanol and supple-
mented where indicated with DKK1-his as described (Lindsley et al., 2006).
Gene expression was induced by addition of dox (250 ng/ml). Hematopoietic
colony assays were as described (Lindsley et al., 2006).
Immunofluorescence
Embryoid bodies (EB) were plated at the indicated time onto Collagen I-coated
slides (BDBiosciences), fixed in 2% formaldehyde in PBS, andblockedwith 1%
BSA/0.5% saponin in PBS. Primary antibodies: biotinylated E-cadherin (2.5 mg/
ml, R and D Systems), N-cadherin (2.5 mg/ml, BD Transduction Laboratories),
cTnT (2 mg/ml, 1C11, Abcam), aSMA (13.3 mg/ml, Sigma), SM-MHC (1:100, Bio-
medical Technologies), Pecam1 (5 mg/ml, 390, eBioscience), VE-cadherin
(2.5 mg/ml, R and D Systems). Secondary detection: FITC F(ab0 )2 a-rat IgG,
Cy3 a-mouse IgG, Cy3 a-mouse IgG1, and FITC a-rabbit IgG (3 mg/ml, Jackson
Immunoresearch Laboratories) and streptavidin-Alexa488 (Molecular Probes).
Nuclei were stained with Hoechst 33342 (1 mg/ml, Molecular Probes).
Flow Cytometry
EBs were dissociated with trypsin and were stained directly or fixed with 2%
formaldahyde and permeabilized with 0.5% saponin before staining. BloodCell Stem Cell 3, 55–68, July 2008 ª2008 Elsevier Inc. 65
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biotin a-mE-cadherin (R&D Systems, 1.25ug/ml), PE a-Flk1 (1 mg/ml,
Avas12a1), PE a-Pecam1 (1 mg/ml, 390), PE a-Tie2 (1 mg/ml, Tek4), and APC
a-PDGFRa (1 mg/ml, APA5) (eBioscience), FITC a-aSMA (230 ng/ml, 1A4,
Sigma), biotin a-VE-cadherin (250 ng/ml, R and D Systems), and a-cTnT
(2 mg/ml, 1C11, Abcam), APC a-CD19 (BD-PharMingen, 1 mg/ml), APC a-
CD3 (BD-PharMingen, 1 mg/ml), APC a-Gr1 (BD-PharMingen, 1 mg/ml), APC
a-cKit (eBioscience, 1 mg/ml), and biotinylated Lineage cocktail (10 ml/ml, Mil-
tenyi). Secondary detection reagents: SA/APC (BD PharMingen, 0.5 mg/ml),
SA/PE-Cy7 (BD Biosciences), and PE or APC a-mouse IgG1 (3 mg/ml, Jackson
Immunoresearch Laboratories). Data were acquired on a FACS Calibur
(Becton Dickinson) and analyzed using FloJo (Tree Star).
Gene Expression Analysis
Large-scale gene expression analysis was performed using MOE430_2.0
arrays (Affymetrix) as described (Lindsley et al., 2006). Data were normalized,
and expression values were modeled using DNA-Chip Analyzer (dChip) (Li and
Hung Wong, 2001). Raw data are available at the Gene Expression Omnibus
(GEO) Repository, accession number GSE5976. RT-PCR analysis was as
described (Lindsley et al., 2006) using primers in Table S2. Cycle numbers
varied according to expression level and were between 25 and 36 cycles.
Mice
Mesp1-Cre mice were obtained from the Riken BioResource Center as cryo-
preserved embryos (Saga et al., 2000). Heterozygous Mesp1Cre/+ mice were
bred to homozygous R26R-GFP+/+ mice (The Jackson Laboratory).
Electrophysiological Studies
A2lox.Mesp1 ESCs were differentiated in the presence of DKK1 alone (days
2–10), or in the presence of DKK1 (days 2–10) and doxycyline (days 2–4) to pro-
duce spontaneously beating clusters. On day 10, cells were lightly dissociated
using trypsin and small clusters were plated on laminin-coated glass cover-
slips. Whole cell recordings were obtained as described in the Supplemental
Experimental Procedures.
SUPPLEMENTAL DATA
The Supplemental Data include seven figures, five tables, and Supplemental
Experimental Procedures and can be found with this article online at http://
www.cellstemcell.com/cgi/content/full/3/1/55/DC1/.
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